Development of a core outcome set for myocardial infarction in clinical trials of traditional Chinese medicine: a study protocol.

ABSTRACT:

Introduction

Myocardial infarction (MI) is the most dangerous complication in patients with coronary heart disease. In China, there is an increasing number of randomised controlled trials (RCTs) of traditional Chinese medicine (TCM) for treating MI. However, the inconsistency of outcome reporting means that a large number of clinical trials cannot be included in systematic reviews to provide the best evidence for clinical practice. The aim of this study is to develop a core outcome set (COS) for future TCM clinical trials of MI, which may improve the consistency of outcome reporting and facilitate the synthesis of data across studies in systematic reviews.

Methods and analysis

We will conduct a systematic review of MI clinical trials with any intervention. Semistructured int

SUBMITTER: Qiu R 

PROVIDER: S-EPMC6924774 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature